Who We Are
Boxer Capital, LLC, is a private biotechnology investment fund based in San Diego, California that invents and invests in new therapeutics across multiple indications in order to create value through improved patient care and outcomes. Founded by the life sciences team at Tavistock Group in 2005, Boxer Capital invests in private and public companies representing the entire drug development lifecycle - from early-stage pre-clinical discovery assets to late-stage clinical and commercial stage companies.
What We Do
Through disciplined analysis, our research and investment team identify opportunities to invest throughout the business life-cycle - from long term positions with mature biotechnology companies that have strong leadership and high growth potential, to building new biotechnology companies from the ground up.
This investment approach has positioned us as one of the premier life science investment firms in the industry and provided the ability to invest in research that will lead ground-breaking developments in the medical community.
Our expert team includes scientists and clinicians who have been at the forefront of research and discovery across multiple therapeutic indications, including cardiovascular health, oncology, and neurological disease. Several members of our team continue to practice medicine and have had the privilege of leading clinical development for multiple drugs that are treating patients today.
This unique combination of medical and investing expertise has led to a 16-year proven track record, generating out-sized returns for our key investor, Tavistock Group, and the Boxer Capital team.